Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News

Catheter cryoablation effective for persistent AFib in pivotal trial
- Author:
- Mitchel L. Zoler, PhD
NATIONAL HARBOR, MD. – Cryoballoon becomes the first catheter ablating device to show efficacy and safety for persistent AFib in an FDA-approved...
News

AFib link with titin mutations warrants selected genetic testing
- Author:
- Mitchel L. Zoler, PhD
Evidence strongly links loss-of-function mutations in the titin gene with AFib, and patients are now seeking genetic testing.
News

Carbs, fat, and mortality: Types matter more than levels
- Author:
- Mitchel L. Zoler, PhD
Low-carb or -fat diets mean less for survival than food types. Eating unrefined carbs and unsaturated fats...
News

FDA advisers set high bar for new opioids
- Author:
- Mitchel L. Zoler, PhD
Two days of FDA discussion over three new opioids seeking U.S. approval highlighted the barriers these drugs now face.
News

Coronary function testing during angiography boosts 1-year angina outcomes
- Author:
- Mitchel L. Zoler, PhD
PHILADELPHIA – Diagnosing coronary microvascular disease or vasospasm during angiography improved angina outcomes; new findings help show why.
News

FDA committee rejects oxycodegol, new opioid designed for less abuse
- Author:
- Mitchel L. Zoler, PhD
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
News
Half of SLE patients have incident neuropsychiatric events
- Author:
- Mitchel L. Zoler, PhD
Average 8-year follow-up of an international lupus inception cohort showed that 52% developed a neuropsychiatric event.
News

Diabetes boosts bariatric surgery complications
- Author:
- Mitchel L. Zoler, PhD
LAS VEGAS – In addition, patients with insulin-dependent diabetes had significantly higher rates of these and other complications, compared with...
News

HRS urges consumers to direct questions about wearables’ data to clinicians
- Author:
- Mitchel L. Zoler, PhD
The Heart Rhythm Society teamed with a consumer group to release public guidance on how to use cardiac data from...
News

Evidence builds for bariatric surgery’s role in cancer prevention
- Author:
- Mitchel L. Zoler, PhD
LAS VEGAS – Some patients are trying to reduce their future risk for cancer with the procedure.
News

Bariatric surgery candidates show high prevalence of thrombophilia
- Author:
- Mitchel L. Zoler, PhD
LAS VEGAS – Thrombophilia screening of 1,075 bariatric-surgery candidates identified 52% as positive, which...
News

Score predicts bariatric surgery’s benefits for obesity, type 2 diabetes
- Author:
- Mitchel L. Zoler, PhD
LAS VEGAS – The calculator can estimate the 10-year risk for death and cardiovascular disease events for patients if their clinical status...
News

ODYSSEY Outcomes: Alirocumab cut stroke, PAD, VTE
- Author:
- Mitchel L. Zoler, PhD
PHILADELPHIA – Prespecified outcomes from the alirocumab outcomes trial showed the drug significantly cut PAD and VTE events, as well as ischemic...
News

New hypertension performance measures boost 130/80 mm Hg target
- Author:
- Mitchel L. Zoler, PhD
PHILADELPHIA – Hypertension performance and quality measures from the AHA and ACC provide a guide for implementing the 2017 hypertension guideline...
News

Nearly 25% of U.S. adults take an obesogenic prescription drug
- Author:
- Mitchel L. Zoler, PhD
The 2013-2016 analysis also showed a strong link between obesogenic drug use and increasing obesity severity.